Medical Oncologist
CION Cancer Clinics
Treatment options when liver cancer involves the portal vein | CION Cancer Clinics
When a primary liver cancer has grown into the portal vein, the main treatment is usually medicine given through the whole body, such as an immunotherapy combination or a targeted tablet. Surgery and transplant are usually no longer offered, and TACE is used carefully. This page explains what the team weighs, which options fit where, and who they do not suit. At CION Cancer Clinics, a multidisciplinary tumour board weighs your liver function and your scans before recommending any treatment.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What treatment is possible when HCC has grown into the portal vein?
- What does the team look at before choosing a treatment?
- What happens after the scan shows portal vein involvement?
- Which treatments are used, and when?
- What do families often get wrong about portal vein tumour?
- When are these treatments not the right choice?
- What this page cannot tell you
- Common questions about portal vein involvement
The short answer
What treatment is possible when HCC has grown into the portal vein?
When a primary liver cancer (hepatocellular carcinoma, or HCC) has grown into the portal vein, the main treatment is usually medicine given through the whole body. For most people, surgery and transplant are no longer offered, and TACE is used far more carefully, if at all.
This page is about cancer that started in the liver. If your scan shows cancer that spread to the liver from the bowel, breast or another organ, the plan is different and is led by the team treating that first cancer.
Why the portal vein matters so much
The portal vein carries blood from the gut into the liver. When tumour grows inside it, doctors call it a portal vein tumour thrombus (PVTT). It tells the team the cancer has learned to travel through blood vessels. That is why most guidelines place it in the advanced group, called BCLC stage C, even if the tumour itself is not large.
A tumour thrombus is not an ordinary clot
People with cirrhosis can also get a plain blood clot in the portal vein, which is not cancer. The two are treated very differently. Before any plan is made, the scan has to show which one it is. Our page on telling a tumour thrombus from a blood clot explains how.
Advanced does not mean untreatable. It means the treatment changes.What decides the plan
What does the team look at before choosing a treatment?
Three things decide almost every plan. The tumour is only one of them.
How far into the vein
Tumour in a small side branch is very different from tumour filling the main trunk. Doctors grade this from Vp1, a small branch, to Vp4, the main portal vein. The grade changes which options are safe.
Explained in full
How well the liver works
Most people with HCC also have cirrhosis. The Child-Pugh score, built from blood tests such as bilirubin (the yellow pigment) and albumin (a protein the liver makes), and from fluid in the belly and confusion, shows how much liver reserve is left. Weaker reserve narrows every option.
How fit you are
Whether you are up and about most of the day, or resting in bed for much of it, matters as much as any scan. Stronger treatments need a body that can carry them.
What else is going on
Active hepatitis B, bleeding varices (swollen veins in the food pipe), kidney problems and spread outside the liver all shape the choice. Varices are often checked with an endoscopy before some medicines are started.
Not sure whether this applies to you?
Ask an oncologistFrom scan to plan
What happens after the scan shows portal vein involvement?
A proper scan of the liver
A triple-phase CT or an MRI shows whether the material in the vein lights up like the tumour does. CION arranges these scans through diagnostic partners if you do not already have them.
Blood tests of liver function
Bilirubin, albumin, INR (how well the blood clots) and AFP (a protein some liver cancers make) are checked. These set the Child-Pugh score.
The tumour board
Medical oncologists, surgeons, radiologists and radiation oncologists look at the same scans together. At CION, the liver tumour board reviews every case before a plan is confirmed.
A written plan you can question
You are told which option is recommended, why, and what the alternatives were. Ask what the goal is: control, comfort, or both.
Side by side
Which treatments are used, and when?
Treatment
Where it usually fits
Immunotherapy combinations, such as atezolizumab plus bevacizumab
Usually the first choice when liver function is good. Given at CION centres.
Targeted tablets, such as lenvatinib or sorafenib
When immunotherapy is not safe or not suitable. Given at CION centres.
Y-90 radioembolisation (TARE)
For selected people with branch involvement. Coordinated through partner hospitals.
Focused radiation to the thrombus
Sometimes added to other treatment. Coordinated through partner hospitals.
TACE
Used cautiously, and usually avoided when the main trunk is blocked.
Supportive and palliative care
For everyone, alongside any treatment, and the main care when the liver is very weak.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
What do families often get wrong about portal vein tumour?
"It is just a clot. A blood thinner will clear it."
A tumour thrombus is cancer growing inside the vein, not a clot of blood. Blood thinners do not shrink it. Whether a blood thinner is needed at all is a separate decision your team makes.
"If they will not operate, nothing can be done."
Medicine through the bloodstream is now the main treatment for this situation, and many people are well enough to have it. Surgery being ruled out is not the same as treatment being ruled out.
"A transplant will replace the liver and the problem with it."
Once tumour is inside the main veins, cancer is likely to have travelled further. Transplant centres generally do not offer a transplant in this situation, because the cancer would be expected to return in the new liver.
"TACE is the standard liver cancer procedure, so we should ask for it."
TACE works by blocking the artery to the tumour. If the portal vein is also blocked, the healthy liver can lose too much of its blood supply. That is why TACE is used carefully here, if at all.
Who this does not suit
When are these treatments not the right choice?
Immunotherapy and targeted tablets are not right for everyone with a portal vein tumour. When liver reserve is very poor, with deep jaundice, fluid that keeps coming back or repeated confusion, these medicines can do more harm than good. Comfort-focused care is then the honest recommendation, and it is still active care.
Immunotherapy has its own exclusions
People with some autoimmune diseases, a past liver transplant, or untreated varices that have bled may not be able to have immunotherapy combinations safely. Our page on who cannot have atezolizumab plus bevacizumab covers this.
Y-90 and radiation have limits too
They need enough healthy liver left, and a tumour that can be reached safely. Y-90 is not offered at every centre in India and is quoted separately. Your team will tell you where a procedure takes place.
Doing less is sometimes the kinder plan. A good team will say so plainly.Being straight with you
What this page cannot tell you
It cannot tell you which treatment is right for your father, mother or spouse. That depends on the exact grade of vein involvement, the blood tests from this week and how well they are managing at home. Only a team that has seen the scans can weigh those together.
It cannot predict how long anyone will live
Statistics describe large groups, not one person. If you want to talk about what to expect, ask the oncologist directly. They can speak about your family member, which no website can.
Who this page does not apply to
It does not apply to cancer that spread to the liver from elsewhere, to children with liver tumours, or to a plain portal vein clot with no cancer in it. If a report says "bland thrombus", read our page on portal vein tumour thrombosis and ask which one your scan shows.
Questions we are asked
Common questions about portal vein involvement
Can liver cancer with portal vein thrombosis be treated?
Yes, in many cases. The usual treatment is medicine given through the whole body, such as an immunotherapy combination or a targeted tablet. Radiation or Y-90 are sometimes added. What is offered depends on liver function and fitness, so the answer is individual.
Can the tumour be removed by surgery?
For most people, no. Tumour inside the portal vein usually means cancer cells are already moving through the blood, so removing part of the liver does not remove the disease. A few specialist centres consider surgery for very limited branch involvement. CION's surgical oncologists can tell you whether that applies.
Is a liver transplant possible?
Generally not. Transplant centres follow strict rules about which cancers can be transplanted, and tumour in the main veins usually rules it out. Rules differ between centres and change over time, so the final word comes from a licensed transplant centre, not from this page.
Why will the doctor not do TACE?
TACE blocks the artery feeding the tumour. The healthy liver relies on both the artery and the portal vein. If the portal vein is already blocked by tumour, blocking the artery too can damage the rest of the liver. Our page on when TACE is not safe explains more.
Is atezolizumab plus bevacizumab available in India?
Yes, both medicines are available in India and are given as drips at CION centres. Cost depends on the plan and on any insurance or scheme cover. Your team will give you a written estimate. The combination page explains how it works and its side effects.
Do we need a blood thinner?
Not usually because of the tumour thrombus itself, since a blood thinner does not shrink cancer. Some people also have a plain clot, or another reason for a blood thinner. Bleeding risk from varices has to be weighed first. Never start or stop one without your doctor.
Is a second opinion worth it here?
Often, yes. Reading vein involvement on a scan takes experience, and an ordinary clot can be mistaken for tumour or the other way round. Bring every scan on a disc, the reports and recent blood tests. CION's tumour board can review them and explain the options.
What should we ask at the next appointment?
Ask whether the vein contains tumour or clot, which grade it is, and what the Child-Pugh score is. Then ask what the recommended treatment aims to do, what the alternatives were, and what happens if the liver gets weaker. Write the answers down for the family.
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- EASL — EASL Clinical Practice Guidelines: management of hepatocellular carcinoma
- American Cancer Society — Treatment of Liver Cancer, by Stage
- Merck Manual Consumer Version — Portal Vein Thrombosis
- RadiologyInfo.org (RSNA/ACR) — Radioembolization (Y90)
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Portal vein tumour thrombosis explainedWhat the finding on the scan actually isVp1 to Vp4: how portal vein involvement is gradedThe grade that decides which options are safeY-90 with portal vein thrombosisWhen radioembolisation is consideredRadiation for portal vein tumour thrombusHow focused radiation can be added
Talk to us
Has a scan shown tumour in the portal vein?
Send us the scans and recent blood tests, and the liver tumour board can review them and explain the options in plain words. One helpline serves every CION centre.